Clinical trial
A Multicenter, Randomized, Parallel, Double Blind, Placebo-controlled Phase III Study to Evaluate Safety and Efficacy of Ilaprazole 20mg in Patients With Non-erosive Reflux Disease(NERD)
NCT03444883 is registered in ClinicalTrials.gov with Il-Yang Pharm. Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Parallel, Double Blind, Placebo-controlled Phase III Study to Evaluate Safety and Efficacy of Ilaprazole 20mg in Patients With Non-erosive Reflux Disease(NERD)
- Lead sponsor
- Il-Yang Pharm. Co., Ltd.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 31, 2018
- Completion date
- February 25, 2020
- Enrollment
- 277 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.